Quarterly report · Q1
6776.TEDINET S100RM5X
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.3bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥205m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥38m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥347m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥752m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥140m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥347m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥140m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥235m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥104m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥218m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥81m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥28.1bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥27.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥22.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.4bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥18.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.8bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.86 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.99 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.16 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 29.0% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 41
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥10m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥75m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥115m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥115m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥9m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥10m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥231m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥71m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥71m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥57m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥6.3bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥6.3bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥10m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥204m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥28m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥28m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥512m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥512m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥47m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥187m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥168m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥28m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.2bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥4.2bn |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥1m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥71m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥71m |
| jpcrp040300-q1r_E01813-000Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥58m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥5.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥28m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥38m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 337
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 71000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 4936000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 4936000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 10000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 18000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 28000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -28000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 4192000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 187000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 512000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 71000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 4965000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -28000000 | JPY |
| Net sales | Prior1YTDDuration | 4936000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | -1000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 28000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | -47000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 58000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 38000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 0 | JPY |
| Operating income | Prior1YTDDuration | 38000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 5151000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 115000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 1001000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 71000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 6339000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 6339000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 10000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 10000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -10000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 5162000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | 115000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | 1001000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 71000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 6350000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -10000000 | JPY |
| Net sales | CurrentYTDDuration | 6339000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInJapanReportableSegmentsMember | 231000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInChinaReportableSegmentsMember | -9000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E01813-000InjectionMoldingBusinessInAmericaReportableSegmentsMember | -75000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E01813-000RealEstateBusinessReportableSegmentsMember | 57000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |